The host type I interferon response to viral and bacterial infections

Cell Research

Volumn 15, Issue 6, 2005, Pages 407-422

  Perry, Andrea K ^a   Chen, Gang ^b   Zheng, Dahai ^b   Tang, Hong ^b   Cheng, Genhong ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Listeria monocytogenes; Pattern recognition receptors; Signaling mechanisms; Toll like receptors; Type I interferons; Virus infections

Indexed keywords

BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES; POSIBACTERIA;

CELL SURFACE RECEPTOR; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; DNA BINDING PROTEIN; IKK I KINASE; IKK-I KINASE; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; IRF3 PROTEIN, HUMAN; IRF7 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN KINASE R; PROTEIN SERINE THREONINE KINASE; RNA HELICASE; TBK1 PROTEIN, HUMAN; TLR7 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR;

ANIMAL; BACTERIAL INFECTION; BETAHERPESVIRINAE; BIOSYNTHESIS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOLOGY; METABOLISM; ORTHOMYXOVIRUS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; DEAD-BOX RNA HELICASES; DNA-BINDING PROTEINS; EIF-2 KINASE; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; MEMBRANE GLYCOPROTEINS; MUROMEGALOVIRUS; ORTHOMYXOVIRIDAE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RNA HELICASES; SIMPLEXVIRUS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS DISEASES;

EID: 23944516870     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290309     Document Type: Review

References (134)

1. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147:258-67.
2. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. TypeI interferons (α/β) in immunity and autoimmunity. Annu Rev Immunol 2005; 23:307-35.
3. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987-95.
4. Taniguchi T, Takaoka A. The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002; 14:111-6.
5. Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 2004; 24:439-54.
6. Fitzgerald KA, McWhirter SM, Faia KL, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4:491-6.
7. McWhirter SM, Fitzgerald KA, Rosains J, et al. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 2004; 101:233-8.
8. Hemmi H, Takeuchi O, Sato S, et al. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 2004; 199:1641-50.
9. Perry AK, Chow EK, Goodnough JB, et al. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 2004; 199:1651-8.
10. Sharma S, tenOever BR, Grandvaux N, et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003; 300:1148-51.
11. Barnes B, Lubyova B, Pitha PM. On the role of IRF in host defense. J Interferon Cytokine Res 2002; 22:59-71.
12. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19:623-55.
13. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430:257-63.
14. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
15. Kawai T, Takeuchi O, Fujita T, et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001; 167:5887-94.
16. Doyle S, Vaidya S, O'Connell R, et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002; 17: 251-63.
17. Yamamoto M, Sato S, Mori K, et al. Cutting edge: a novel Toll/ IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J Immunol 2002; 169:6668-72.
18. Fitzgerald KA, Rowe DC, Barnes BJ, et al. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll Adapters TRAM and TRIF. J Exp Med 2003; 198:1043-55
19. Hoebe K, Du X, Georgel P, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424:743-8.
20. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301:640-3.
21. Oshiumi H, Matsumoto M, Funami K, et al. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat Immunol 2003; 4:161-7.
22. Yamamoto M, Sato S, Hemmi H, et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003; 4:1144-50
23. Oshiumi H, Sasai M, Shida K, et al. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-β. J Biol Chem 2003; 278:49751-62.
24. Liu YJ. IPC: Professional Type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23:275-306.
25. Haynes LM, Moore DD, Kurt-Jones EA, et al. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 2001; 75:10730-7.
26. Kurt-Jones EA, Popova L, Kwinn L, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1:398-401.
27. Rassa JC, Meyers JL, Zhang Y, et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A 2002; 99: 2281-6.
28. Sakaguchi S, Negishi H, Asagiri M, et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-β gene expression and endotoxin shock. Biochem Biophys Res Commun 2003; 306:860-6.
29. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001; 413:732-8.
30. Matsumoto M, Funami K, Tanabe M, et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171:3154-62.
31. Tabeta K, Georgel P, Janssen E, et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 2004; 101:3516-21.
32. Edelmann KH, Richardson-Burns S, Alexopoulou L, et al. Does Toll-like receptor 3 play a biological role in virus infections? Virology 2004; 322:231-8.
33. Lopez CB, Moltedo B, Alexopoulou L, et al. TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J Immunol 2004; 173:6882-9.
34. Honda K, Sakaguchi S, Nakajima C, et al. Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci U S A 2003; 100:10872-7.
35. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5:730-7.
36. Lund JM, Alexopoulou L, Sato A, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 2004; 101:5598-603.
37. Wang T, Town T, Alexopoulou L, et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004; 10:1366-73.
38. Han KJ, Su X, Xu LG, et al. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-κB activation and apoptosis pathways. J Biol Chem 2004; 279:15652-61.
39. Jiang Z, Mak TW, Sen G, Li X. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β. Proc Natl Acad Sci U S A 2004; 101:3533-8.
40. Sato S, Sugiyama M, Yamamoto M, et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappaB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 2003; 171:4304-10.
41. Sarkar SN, Peters KL, Elco CP, et al. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 2004; 11:1060-7.
42. Gohda J, Matsumura T, Inoue J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling. J Immunol 2004; 173:2913-7.
43. Meylan E, Burns K, Hofmann K, et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 2004; 5: 503-7.
44. Ehrhardt C, Kardinal C, Wurzer WJ, et al. Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett 2004; 567:230-8.
45. Diebold SS, Kaisho T, Hemmi H, et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303:1529-31.
46. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004; 303:1526-9
47. Hornung V, Schlender J, Guenthner-Biller M, et al. Replication-dependent potent IFN-α induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J Immunol 2004; 173:5935-43.
48. Crozat K, Beutler B. TLR7: A new sensor of viral infection. Proc Natl Acad Sci U S A 2004; 101:6835-6.
49. Barchet W, Krug A, Cella M, et al. Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways. Eur J Immunol 2005; 35:236-42.
50. Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002; 3:196-200.
51. Lee J, Chuang TH, Redecke V, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci U S A 2003; 100:6646-51.
52. Jurk M, Heil F, Vollmer J, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002; 3:499.
53. Heil F, Ahmad-Nejad P, Hemmi H, et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 2003; 33:2987-97.
54. von Krogh G, Lacey CJ, Gross G, et al. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000; 76:162-8.
55. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5.
56. Krug A, French AR, Barchet W, et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004; 21:107-19.
57. Krug A, Luker GD, Barchet W, et al. Herpes simplex virus type 1 (HSV-1) activates murine natural interferon-producing cells (IPC) through Toll-like receptor 9. Blood 2004; 103:1433-7.
58. Lund J, Sato A, Akira S, et al. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198:513-20.
59. Bauer M, Redecke V, Ellwart JW, et al. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J Immunol 2001; 166:5000-7.
60. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20:709-60.
61. Honda K, Yanai H, Mizutani T, et al. Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 2004; 101:15416-21.
62. Kawai T, Sato S, Ishii KJ, et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5:1061-8.
63. Ito T, Amakawa R, Kaisho T, et al. Interferon-α and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002; 195:1507-12.
64. Diebold SS, Montoya M, Unger H, et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003; 424:324-8.
65. Doyle S, Vaidya S, O'Connell R, et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002; 17:251-63
66. Asselin-Paturel C, Boonstra A, Dalod M, et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001; 2:1144-50.
67. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194:863-9.
68. Krug A, Luker GD, Barchet W, et al. Herpes Simplex Virus type 1 (HSV-1) activates murine Natural Interferon-Producing cells (IPC) through Toll-Like Receptor 9. Blood 2004; 103:1433-7
69. tenOever BR, Sharma S, Zou W, et al. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J Virol 2004; 78:10636-49.
70. Saunders LR, Barber GN. The dsRNA binding protein family: critical roles, diverse cellular functions. Faseb J 2003; 17:961-83.
71. Yang YL, Reis LF, Pavlovic J, et al. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. Embo J 1995; 14:6095-106.
72. Chu WM, Ostertag D, Li ZW, et al. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 1999; 11:721-31.
73. Kumar A, Yang YL, Flati V, et al. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. Embo J 1997; 16:406-16.
74. Katze MG, He Y, Gale M, Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2:675-87.
75. Smith EJ, Marie I, Prakash A, et al. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein. J Biol Chem 2001; 276:8951-7.
76. Bergmann M, Garcia-Sastre A, Carnero E, et al. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 2000; 74:6203-6.
77. Balachandran S, Roberts PC, Brown LE, et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 2000; 13:129-41.
78. Wang X, Li M, Zheng H, et al. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of α/β interferon. Dec. J Virol 2000; 74: 11566-73.
79. Hatada E, Saito S, Fukuda R. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol 1999; 73:2425-33.
80. Hogle JM. Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol 2002; 56:677-702.
81. Lakadamyali M, Rust MJ, Zhuang X. Endocytosis of influenza viruses. Microbes Infect 2004; 6:929-36.
82. Garner JA. Herpes simplex virion entry into and intracellular transport within mammalian cells. Adv Drug Deliv Rev 2003; 55:1497-513.
83. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes simplex virus type-1 induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci U S A 2004; 101:11416-21.
84. Taddeo B, Luo TR, Zhang W, Roizman B. Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis. Proc Natl Acad Sci U S A 2003; 100:12408-13.
85. Sato A, Iwasaki A. Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc Natl Acad Sci U S A 2004; 101:16274-9.
86. Kurt-Jones EA, Chan M, Zhou S, et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 2004; 101:1315-20.
87. Krmpotic A, Bubic I, Polic B, et al. Pathogenesis of murine cytomegalovirus infection. Microbes Infect 2003; 5:1263-77.
88. Spear PG. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 2004; 6:401-10.
89. Letchworth GJ, Rodriguez LL, Del cbarrera J. Vesicular stomatitis. Vet J 1999; 157:239-60.
90. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284:1835-7.
91. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5:919-23.
92. Kadowaki N, Antonenko S, Liu YJ. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J Immunol 2001; 166:2291-5.
93. Dalod M, Salazar-Mather TP, Malmgaard L, et al. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 2002; 195:517-28.
94. Coccia EM, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004; 34:796-805.
95. Reis e Sousa C. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 2004; 16:27-34.
96. Brawand P, Fitzpatrick DR, Greenfield BW, et al. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J Immunol 2002; 169:6711-9.
97. Dai J, Megjugorac NJ, Amrute SB, Fitzgerald-Bocarsly P. Regulation of IFN regulatory factor-7 and IFN-α production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J Immunol 2004; 173:1535-48.
98. Izaguirre A, Barnes BJ, Amrute S, et al. Comparative analysis of IRF and IFN-α expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 2003; 74:1125-38.
99. Barchet W, Cella M, Odermatt B, et al. Virus-induced interferon α production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med 2002; 195:507-16.
100. Shimada T, Kawai T, Takeda K, et al. IKK-i, a novel lipopolysaccharide- inducible kinase that is related to IκB kinases. Int Immunol 1999; 11:1357-62.
101. Tojima Y, Fujimoto A, Delhase M, et al. NAK is an IkappaB kinase-activating kinase. Nature 2000; 404:778-82.
102. Utaisincharoen P, Anuntagool N, Limposuwan K, et al. Involvement of β interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages. Infect Immun 2003; 71:3053-7.
103. Sing A, Merlin T, Knopf HP, et al. Bacterial induction of β interferon in mice is a function of the lipopolysaccharide component. Infect Immun 2000; 68:1600-7.
104. Eloranta ML, Sandberg K, Ricciardi-Castagnoli P, et al. Production of interferon-α/β by murine dendritic cell lines stimulated by virus and bacteria. Scand J Immunol 1997; 46:235-41.
105. Yaegashi Y, Nielsen P, Sing A, et al. Interferon β, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice. J Exp Med 1995; 181:953-60.
106. Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol 2004; 4:812-23.
107. Havell EA. Augmented induction of interferons during Listeria monocytogenes infection. J Infect Dis 1986; 153:960-9.
108. O'Riordan M, Yi CH, Gonzales R, et al. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc Natl Acad Sci U S A 2002; 99:13861-6.
109. Stockinger S, Materna T, Stoiber D, et al. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J Immunol 2002; 169:6522-9.
110. Auerbuch V, Brockstedt DG, Meyer-Morse N, ετ αλ. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med 2004; 200:527-33.
111. Carrero JA, Calderon B, Unanue ER. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med 2004; 200:535-40.
112. McCaffrey RL, Fawcett P, O'Riordan M, et al. A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc Natl Acad Sci U S A 2004; 101:11386-91.
113. O'Connell RM, Saha SK, Vaidya SA, et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 2004; 200:437-45.
114. O'Connell RM, Vaidya SA, Perry AK, et al. Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TANK-Binding Kinase 1. J Immunol 2005; 174:1602-7.
115. Stockinger S, Reutterer B, Schaljo B, et al. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J Immunol 2004; 173:7416-25.
116. Zheng SJ, Jiang J, Shen H, Chen YH. Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol 2004; 173:5652-8.
117. Remoli ME, Giacomini E, Lutfalla G, et al. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J Immunol 2002; 169:366-74.
118. Weiden M, Tanaka N, Qiao Y, et al. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein β expression. J Immunol 2000; 165:2028-39.
119. Giacomini E, Iona E, Ferroni L, et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001; 166:7033-41.
120. Manca C, Tsenova L, Bergtold A, et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α /β. Proc Natl Acad Sci U S A 2001; 98: 5752-7.
121. Bouchonnet F, Boechat N, Bonay M, Hance AJ. α/β interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infect Immun 2002; 70:3020-5.
122. Stark GR, Kerr IM, Williams BR, et al. How cells respond to interferons. Annu Rev Biochem 1998; 67:227-64.
123. Player MR, Torrence PF. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. May. Pharmacol Ther 1998; 78: 55-113.
124. Torrence PF, Maitra RK, Lesiak K, et al. Targeting RNA for degradation with a (2′-5′)oligoadenylate-antisense chimera. Proc Natl Acad Sci U S A 1993; 90:1300-4.
125. Kochs G, Haller O. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc Natl Acad Sci U S A 1999; 96:2082-6.
126. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol 2004; 22:405-29.
127. Zuniga EI, McGavern DB, Pruneda-Paz JL, et al. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 2004; 5: 1227-34.
128. Laing KJ, Secombes CJ. Chemokines. Dev Comp Immunol 2004; 28:443-60.
129. Servant MJ, Tenoever B, Lin R. Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function. J Interferon Cytokine Res 2002; 22:49-58.
130. Alcami A, Symons JA, Smith GL. The vaccinia virus soluble α/β interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 2000; 74:11230-9.
131. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14:778-809.
132. Caraglia M, Marra M, Pelaia G, et al. α-interferon and its effects on signal transduction pathways. J Cell Physiol 2005; 202:323-35.
133. Sato M, Suemori H, Hata N, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 2000; 13:539-48.
134. Collins SE, Noyce RS, Mossman KL. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 2004; 78:1706-17.